Does Dr. GHULAM AFTAB have financial conflicts of interest?

Dr. GHULAM AFTAB (MD) has received a total of $5,655 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $5,655 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. GHULAM AFTAB?

According to CMS Open Payments data, Dr. GHULAM AFTAB received funding from INTUITIVE SURGICAL ($4,441), ASTRAZENECA PHARMACEUTICALS ($406), and ACTELION PHARMACEUTICALS US ($152).

Does Dr. GHULAM AFTAB receive research grants or speaking fees?

Dr. GHULAM AFTAB has received $5,655 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. GHULAM AFTAB

MDReal-Time Hydrated

Specialty: Internal Medicine, Critical Care Medicine

Practice Location: LAS VEGAS, NV 89148

NPI Number: 1275987463

LIFETIME INDUSTRY VALUE

$5,655

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. AFTAB is a verified Internal Medicine, Critical Care Medicine practitioner based in LAS VEGAS, NV.

Between 2021 and 2024, Dr. AFTAB had an overall industry promotional and research financial footprint of $5,655 as recorded in the federal CMS Open Payments database.

$5,655 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AFTAB's primary funding source is INTUITIVE SURGICAL, which accounts for $4,441 (representing 78.5% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

INTUITIVE SURGICAL

Rank 1

$4,441

78.5%

ASTRAZENECA PHARMACEUTICALS

Rank 2

$406

7.2%

ACTELION PHARMACEUTICALS US

Rank 3

$152

2.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.